Atilla, E. Et Al. 2015. Is Initial CD3+ T Cell Dose in Donor Lymphocyte Infusion for Relapsed Hematological Malignancies a Prognostic Determinant?. BLOOD , vol.126, no.23 , 5483.

Atilla, E., Ataca, P., Toprak, S. K., Yuksel, M. K., Topcuoglu, P., Arslan, O., ... Ozcan, M.(2015). Is Initial CD3+ T Cell Dose in Donor Lymphocyte Infusion for Relapsed Hematological Malignancies a Prognostic Determinant?. BLOOD , vol.126, no.23, 5483.

Atilla, Erden Et Al. "Is Initial CD3+ T Cell Dose in Donor Lymphocyte Infusion for Relapsed Hematological Malignancies a Prognostic Determinant?," BLOOD , vol.126, no.23, 5483, 2015

Atilla, Erden Et Al. "Is Initial CD3+ T Cell Dose in Donor Lymphocyte Infusion for Relapsed Hematological Malignancies a Prognostic Determinant?." BLOOD , vol.126, no.23, pp.5483, 2015

Atilla, E. Et Al. (2015) . "Is Initial CD3+ T Cell Dose in Donor Lymphocyte Infusion for Relapsed Hematological Malignancies a Prognostic Determinant?." BLOOD , vol.126, no.23, p.5483.

@article{article, author={Erden Atilla Et Al. }, title={Is Initial CD3+ T Cell Dose in Donor Lymphocyte Infusion for Relapsed Hematological Malignancies a Prognostic Determinant?}, journal={BLOOD}, year=2015, pages={5483} }